Meeting
2023 ASCO Annual Meeting
Subsets of interferon signaling and response to immune checkpoint blockade.
Authors
Daniel Lee
Yale School of Medicine, New Haven, CT
Daniel Lee , Brooke Horowitch , Min Ding , Sandra Martinez-Morilla , Thazin Nwe Aung , Feriel Ouerghi , Xueting Wang , Wei Wei , William Damsky , Mario Sznol , Harriet M. Kluger , David L. Rimm , Jeffrey Joseph Ishizuka
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9522)
DOI
10.1200/JCO.2023.41.16_suppl.9522
Abstract #
9522
Poster Bd #
285
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Association of cytoreductive nephrectomy and survival in the immune checkpoint inhibitor era.
First Author: Joseph Miccio
Poster
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Lentiviral interferon with immune checkpoint blockade: A novel method for gene therapy in bladder cancer.
First Author: Sharada Mokkapati
Poster
2024 ASCO Genitourinary Cancers Symposium
Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
First Author: Michelle Hsu
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Role of proton pump inhibitors in immune checkpoint inhibitor colitis.
First Author: Roshini Pradeep